Kuvatris Therapeutics Inc Sustainability Reports
A clinical-stage biopharmaceutical company focused on developing anti-purinergic drug therapies for neurodevelopmental disorders, including Autism Spectrum Disorder (ASD).
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
1 reports from 2023 to 2023
Company Profile
A clinical-stage biopharmaceutical company focused on developing anti-purinergic drug therapies for neurodevelopmental disorders, including Autism Spectrum Disorder (ASD).
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
